ESR1 and breast carcinoma: As to other cancer types, the NAV1 promoter hypomethylation was observed in hormone receptor positive (expressing the estrogen receptor, ER+ and/or progesterone receptor, PR+) breast cancers [36] which seems to be consistent with our results.